Human Papillomavirus (HPV) and Related Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Infectious Agents and Cancer".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 4936
Special Issue Editor
Interests: HPV infections; cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Currently, infection with high-risk human papillomavirus (HR-HPV) is estimated to be the primary etiological factor for approximately 5% of all malignant tumors. HR-HPV infection is a well-established risk factor in the development of certain anogenital cancers, including cervical, vulvar, penile, and anal cancers. Recently, increasing attention has been directed toward the role of this infection in the development of other types of malignant tumors. Understanding the prevalence of HPV infection across various malignant tumor types may enhance our comprehension of the carcinogenesis process and assist in identifying novel prognostic and/or predictive factors in non-anogenital cancers. Although HPV infection is a recognized risk factor in the aforementioned cancers, its significance in the development of many other malignant tumors remains under investigation. Additionally, methods for detecting transcriptionally active infection, in particular, require further research. Therefore, we warmly invite you to submit your publication to the Special Issue of Cancers entitled “Human Papillomavirus (HPV) and Related Cancer”.
Prof. Dr. Beata Biesaga
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV
- carcinogenesis
- methods of virus identification diagnostics
- prognostification
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
